Amsterdam-based Tebi Announces €30 Million Investment Led by Alphabet growth fund CapitalG to transform hospitality operations
10.6.2025 15:05:00 CEST | Business Wire | Press Release
Tebi, the Amsterdam-based startup developing an all-in-one financial operating system for hospitality, today announced a €30 million investment led by Alphabet independent growth fund CapitalG, with participation from existing investor Index Ventures. This follows Tebi’s €20 million Series A announced just six months ago and brings the company’s total funding to €56 million.
The financing reflects the company’s momentum across product innovation, hiring and expansion into new markets. The investment will support Tebi’s continued growth in these key areas of focus.
The company was founded in 2021 by technical alumni from Adyen, a €45B Dutch company, including serial entrepreneur Arnout Schuijff as CEO and Rob Vonk as CTO. Tebi is the third company co-founded by Schuijff, who previously served as Adyen’s longtime CTO and co-founder.
Aki Tas, former head of business strategy and operations at Notion, joined last fall as COO to lead the product, marketing, and foundation teams, and Patrick Studener, former COO at Wolt (now part of Doordash) and previous head of European expansion at Uber, joined at the beginning of the year as CCO to lead operational teams.
The investment will fuel Tebi's mission to transform operations for hospitality businesses worldwide. Until now, businesses have had to cobble together difficult-to-use solutions that lack key features, handle back-office tasks slowly and manually, and make it difficult to assess business performance. Tebi is rethinking hospitality technology from the ground-up, unifying the point of sale, payments, inventory management, a kitchen display system, reservations, and QR ordering functionality through an intuitive, mobile-first platform built on an accounting backbone. By being built around the point of sale, Tebi can coordinate both operations and finances for complex hospitality businesses. AI-enabled onboarding enables businesses to get started quickly, while the comprehensive platform simplifies and unifies workflows and makes key business metrics easily viewable.
Merchants across the Netherlands are already processing nine figures of payments annually on the platform. With this new investment, Tebi plans to accelerate product development, expand its reach globally, and grow its team. Beginning today, Tebi will also begin serving the UK market, marking the beginning of a broader global expansion strategy (UK customers can find Tebi at tebi.com/gb/).
"Hospitality businesses are the lifeblood of our communities, yet they've been underserved by technology, especially here in Europe," said Arnout Schuijff, co-founder and CEO of Tebi. "No one opens a restaurant or store because they love paperwork and integrating tools; they do it for the passion of serving people. It’s a privilege to build a world-class team devoted to empowering European business owners to free up time to focus on the craft and customers they cherish.”
“We are thrilled to partner with Tebi as they build the operating system for hospitality businesses,” said Alex Nichols, Partner at CapitalG. “Even though most small business front and back office workflows revolve around payments, three-quarters of Europe’s SMB payments are disconnected from software. By unifying these disjointed systems, Tebi is bringing greater efficiency and visibility to small business owners’ daily work. Arnout and his team combine focused customer centricity, speed, and unique founder-market fit. We couldn’t imagine a better team to pursue this massive opportunity.”
"Moving from disconnected systems – our previous POS software, a separate reservations platform, paper kitchen tickets, and a standalone payments provider – to Tebi's single integrated platform led us to embrace a new mindset at Zoldering. We approached it as if we were starting fresh, letting go of old habits to realize a seamless workflow from reservation to service to kitchen. Tebi has not just replaced our old systems; it has enabled a new way of working by unifying our data, streamlining communication between front and back of house, and offering the flexibility to adapt workflows to our specific needs – exactly what's required to maintain the standards expected of a Michelin-starred restaurant,” said Tomas and Job from Zoldering.
Tebi currently employs 35 people and is planning to double its headcount by the end of the year with roles open in Amsterdam and London.
About Tebi
Tebi is an all-in-one financial operating system for independent hospitality businesses. Founded in 2021, Tebi provides a comprehensive, mobile-first solution that includes point of sale, integrated payments, a kitchen display system, reservations, inventory management, QR ordering, and bookkeeping. With its unique pricing model and commitment to merchant success, Tebi is dedicated to empowering hospitality businesses everywhere. To learn more about adopting Tebi for your business, visit www.tebi.com.
Tebi is currently hiring across all functions, including engineering, product management and operations in both Amsterdam and London. Visit Tebi’s careers page to see all open positions.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250610225196/en/
Contacts
Melissa Sobel, melissasobel@capitalg.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom